Sharescart Research Club logo

Ambar Protein Overview

Ambar Protein Industries Ltd. was established in 1992 in Ahmedabad to provide quality edible oil under the brand name Ankur to the consumers of Gujarat. The company’s refining plant is situated at Chandgodar, Dist. Ahmedabad with a capacity of 110 tons of refined oil per day. The main promoter of the company is Shri Prabhudasbhai D. Vachhani. The company’s product portfolio includes Ankur Refined Cottonseed Oil, Ankur Refined Sunflower Oil, Ankur Refined Soybean Oil, and Ankur Refined Corn Oil. Ambar Protein Industries Ltd. caters...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Ambar Protein Key Financials

Market Cap ₹103 Cr.

Stock P/E 10.7

P/B 2.6

Current Price ₹178.8

Book Value ₹ 68.3

Face Value 10

52W High ₹432.9

Dividend Yield 0%

52W Low ₹ 145

Ambar Protein Share Price

₹ | |

Volume
Price

Ambar Protein Quarterly Price

Show Value Show %

Ambar Protein Peer Comparison

Ambar Protein Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 69 86 90 93 89 112 128 117 112 125
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 69 86 90 93 89 112 128 117 112 125
Total Expenditure 67 82 90 90 85 107 124 115 109 122
Operating Profit 2 4 -0 3 4 5 4 2 3 3
Interest 1 1 0 1 1 1 1 1 0 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 3 -1 2 4 4 3 1 2 3
Provision for Tax 0 1 -1 1 1 1 1 1 -0 1
Profit After Tax 1 2 -0 2 3 3 2 1 2 2
Adjustments 0 0 0 -0 0 0 -0 0 0 0
Profit After Adjustments 1 2 -0 2 3 3 2 1 2 2
Adjusted Earnings Per Share 1.4 2.7 -0.8 3 4.7 4.9 4.3 1.3 3.5 3.2

Ambar Protein Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 157 168 195 206 231 284 313 340 345 337 422 482
Other Income 1 0 1 1 0 0 0 1 1 0 1 0
Total Income 158 169 196 207 231 285 314 340 346 338 422 482
Total Expenditure 155 167 193 203 227 278 306 331 338 330 406 470
Operating Profit 2 2 3 4 4 7 8 10 8 8 17 12
Interest 1 1 1 1 1 3 3 3 3 2 2 3
Depreciation 0 0 0 0 0 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 2 3 3 3 4 6 4 4 13 9
Provision for Tax 0 1 0 1 1 2 1 1 1 1 3 3
Profit After Tax 2 1 2 2 2 1 3 4 3 3 10 7
Adjustments 0 0 0 0 0 0 0 -0 0 0 0 0
Profit After Adjustments 2 1 2 2 2 1 3 4 3 3 10 7
Adjusted Earnings Per Share 2.7 1.5 4.2 3.7 3.5 2.2 6 7.7 4.9 5.5 16.8 12.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 25% 7% 8% 10%
Operating Profit CAGR 113% 19% 19% 24%
PAT CAGR 233% 36% 58% 17%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -6% -12% 91% NA%
ROE Average 32% 20% 22% 32%
ROCE Average 28% 18% 18% 18%

Ambar Protein Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 4 6 6 8 10 11 15 19 22 25 35
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 4 5 4 4 3 2 0 0
Other Non-Current Liabilities 0 -1 2 1 3 4 3 3 3 2 2
Total Current Liabilities 9 11 15 18 36 31 29 39 35 34 33
Total Liabilities 13 17 23 31 53 49 50 64 62 61 71
Fixed Assets 4 6 6 6 7 22 21 21 20 19 18
Other Non-Current Assets 0 0 0 6 16 0 0 0 2 1 4
Total Current Assets 8 10 17 19 31 27 29 43 41 41 48
Total Assets 13 17 23 31 53 49 50 64 62 61 71

Ambar Protein Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 1 2 3 1 2 1 1 1 1
Cash Flow from Operating Activities 1 -1 -3 1 1 3 1 -3 6 7 2
Cash Flow from Investing Activities 0 -1 0 -5 -10 -1 -0 -0 0 -0 -0
Cash Flow from Financing Activities -1 1 3 6 7 -0 -2 2 -6 -7 -2
Net Cash Inflow / Outflow 0 -1 1 1 -2 1 -1 -0 0 -0 0
Closing Cash & Cash Equivalent 2 1 2 3 1 2 1 1 1 1 1

Ambar Protein Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.7 1.51 4.19 3.75 3.54 2.17 6 7.74 4.89 5.47 16.78
CEPS(Rs) 3.12 1.91 4.54 4.18 3.99 4.14 8.09 9.97 7.11 7.76 19.06
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 4.24 8.48 10.02 13.77 17.31 19.48 25.48 33.21 38.13 43.6 60.39
Core EBITDA Margin(%) 1.09 1.16 1.29 1.47 1.68 2.12 2.35 2.7 2.09 2.19 3.74
EBIT Margin(%) 1.41 1.16 1.62 1.78 1.75 1.89 2.11 2.53 1.88 1.95 3.63
Pre Tax Margin(%) 0.99 0.81 1.26 1.42 1.23 0.97 1.27 1.74 1.15 1.22 3.09
PAT Margin (%) 0.99 0.52 1.23 1.05 0.88 0.44 1.1 1.31 0.82 0.93 2.29
Cash Profit Margin (%) 1.14 0.65 1.34 1.17 0.99 0.84 1.48 1.69 1.18 1.32 2.6
ROA(%) 11.86 5.91 12.14 7.99 4.85 2.43 6.93 7.78 4.45 5.09 14.63
ROE(%) 99.23 23.82 45.24 31.5 22.76 11.79 26.69 26.38 13.72 13.39 32.28
ROCE(%) 27.73 18.69 22.17 17.45 13.38 14.84 16.53 18.33 12.59 12.91 27.5
Receivable days 2.53 2.32 5.35 5.23 2.29 2.26 3.23 6.74 12.35 15.3 14.83
Inventory Days 10.35 13.12 15.9 15.67 23.69 23.06 18.48 23.68 24.42 21.38 17.51
Payable days 11.62 10.14 9.37 7.22 7.64 5.83 3.83 6.44 7.87 7.95 5.01
PER(x) 0 0 0 0 0 0 0 3.83 43.81 26.6 12.1
Price/Book(x) 0 0 0 0 0 0 0 0.89 5.62 3.34 3.36
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.06 0.07 0.07 0.1 0.13 0.1 0.1 0.14 0.44 0.32 0.34
EV/Core EBITDA(x) 3.98 5.61 4.2 5.2 6.77 4.57 4.02 4.9 19.5 13.69 8.52
Net Sales Growth(%) -2.02 7.41 15.89 5.52 11.9 23.34 10.18 8.44 1.57 -2.28 25.03
EBIT Growth(%) 205.49 -11.32 61.81 15.48 9.92 33.77 23.04 29.8 -24.52 1.32 132.69
PAT Growth(%) 1881.54 -43.94 176.34 -10.49 -5.62 -38.69 176.65 29.02 -36.78 11.82 206.77
EPS Growth(%) 1881.53 -43.94 176.35 -10.49 -5.62 -38.69 176.65 29.03 -36.78 11.82 206.77
Debt/Equity(x) 1.38 1.07 1.8 2.26 2.45 2.41 1.86 1.72 1.34 1.02 0.75
Current Ratio(x) 0.86 0.92 1.1 1.06 0.86 0.88 1 1.11 1.15 1.21 1.45
Quick Ratio(x) 0.37 0.23 0.49 0.59 0.26 0.41 0.4 0.43 0.6 0.61 0.84
Interest Cover(x) 3.37 3.34 4.42 5.04 3.38 2.05 2.51 3.2 2.56 2.68 6.75
Total Debt/Mcap(x) 0 0 0 0 0 0 0 1.92 0.24 0.3 0.22

Ambar Protein Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 70.46 70.46 70.73 70.99 71.35 71.35 71.35 71.35 71.48 72.07
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 29.54 29.54 29.27 29.01 28.65 28.65 28.65 28.65 28.52 27.93
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Ambar Protein News

Ambar Protein Pros & Cons

Pros

  • Company has delivered good profit growth of 58% CAGR over last 5 years
  • Debtor days have improved from 7.95 to 5.01days.

Cons

whatsapp